A detailed history of Loveless Wealth Management LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Loveless Wealth Management LLC holds 25,045 shares of ABBV stock, worth $4.95 Million. This represents 2.51% of its overall portfolio holdings.

Number of Shares
25,045
Previous 25,450 1.59%
Holding current value
$4.95 Million
Previous $4.13 Million 7.03%
% of portfolio
2.51%
Previous 2.33%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 22, 2022

SELL
$137.62 - $174.96 $55,736 - $70,858
-405 Reduced 1.59%
25,045 $3.84 Million
Q1 2022

May 11, 2022

SELL
$131.98 - $163.75 $121,025 - $150,158
-917 Reduced 3.48%
25,450 $4.13 Million
Q4 2021

Feb 14, 2022

BUY
$107.43 - $135.93 $49,310 - $62,391
459 Added 1.77%
26,367 $3.57 Million
Q3 2021

Nov 12, 2021

BUY
$106.4 - $120.78 $4,043 - $4,589
38 Added 0.15%
25,908 $2.8 Million
Q2 2021

Jul 28, 2021

BUY
$105.21 - $117.21 $47,660 - $53,096
453 Added 1.78%
25,870 $2.91 Million
Q1 2021

May 03, 2021

BUY
$102.3 - $112.62 $47,569 - $52,368
465 Added 1.86%
25,417 $2.75 Million
Q4 2020

Jan 27, 2021

SELL
$80.49 - $108.67 $5,795 - $7,824
-72 Reduced 0.29%
24,952 $2.67 Million
Q3 2020

Oct 14, 2020

SELL
$85.91 - $100.83 $11,941 - $14,015
-139 Reduced 0.55%
25,024 $2.19 Million
Q2 2020

Aug 10, 2020

BUY
$73.37 - $98.18 $46,149 - $61,755
629 Added 2.56%
25,163 $2.47 Million
Q1 2020

Apr 20, 2020

BUY
$64.5 - $97.79 $47,085 - $71,386
730 Added 3.07%
24,534 $1.87 Million
Q4 2019

Jan 23, 2020

BUY
$72.13 - $90.25 $1.72 Million - $2.15 Million
23,804 New
23,804 $2.11 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $349B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Loveless Wealth Management LLC Portfolio

Follow Loveless Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Loveless Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Loveless Wealth Management LLC with notifications on news.